Stock Events

Stock Events

Dexcom 

$59.48
522
-$0.56-0.93% Tuesday 20:00

Statistics

Day High
60.95
Day Low
58.98
52W High
89.53
52W Low
54.84
Volume
5,526,204
Avg. Volume
-
Mkt Cap
22.89B
P/E Ratio
26.33
Dividend Yield
-
Dividend
-

Upcoming

Earnings

23JulExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Next
0.32
0.44
0.56
0.68
Expected EPS
0.604557
Actual EPS
N/A

Financials

17.94%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
9.32BRevenue
1.67BNet Income

Analyst Ratings

81.36Average Price Target
The highest estimate is 100.00.
From 11 ratings within the last 6 months. This is not an investment recommendation.
Buy
82%
Hold
9%
Sell
9%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow DXCM. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Abbott Laboratories
ABT
Mkt Cap155.82B
Abbott Laboratories competes with Dexcom in the continuous glucose monitoring (CGM) market, particularly with their FreeStyle Libre system.
Medtronic
MDT
Mkt Cap102.71B
Medtronic is a direct competitor in the CGM and diabetes management market, offering products like the Guardian Connect system.
Tandem Diabetes Care
TNDM
Mkt Cap1.33B
Tandem Diabetes Care partners with Dexcom for CGM integration but also competes in providing comprehensive diabetes management solutions.
Insulet
PODD
Mkt Cap12.12B
Insulet Corporation's Omnipod system is a competitor in the broader diabetes management space, offering an alternative to traditional insulin delivery and monitoring systems.
Senseonics
SENS
Mkt Cap213.2M
Senseonics Holdings offers the Eversense CGM system, providing long-term implantable glucose monitoring, a direct competitor to Dexcom's wearable CGM products.
Novo Nordisk
NVO
Mkt Cap194.57B
Novo Nordisk competes indirectly through their extensive range of diabetes care products, including insulin and non-insulin treatments, which are part of integrated diabetes management.
Sanofi
SNY
Mkt Cap110.4B
Sanofi competes in the diabetes market with its insulin and glucose monitoring solutions, offering an alternative to Dexcom's CGM systems.
Mckesson
MCK
Mkt Cap99.71B
McKesson Corporation, through its distribution of diabetes care products including CGMs, competes in the broader market for diabetes management solutions.
Cardinal Health
CAH
Mkt Cap45.94B
Cardinal Health is involved in the distribution of various healthcare products, including diabetes care supplies, competing in the broader market for diabetes management.

About

There is no Profile data available for DC4.MU.
Show more...
CEO
Mr. Kevin Ronald Sayer
Employees
10200
Country
United States
ISIN
US2521311074

Listings

STU
DE
DC4.STU
MU
DE
DC4.MU
MI
IT
1DXCM.MI
XETRA
DE
DC4.XETRA

0 Comments

Share your thoughts

FAQ

What is Dexcom stock price today?▼
The current price of DXCM is $59.48 USD — it has decreased by -0.93% in the past 24 hours. Watch Dexcom stock price performance more closely on the chart.
What is Dexcom stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Dexcom stocks are traded under the ticker DXCM.
Is Dexcom stock price growing?▼
DXCM stock has risen by +3.34% compared to the previous week, the month change is a -5.9% fall, over the last year Dexcom has showed a -27.05% decrease.
What is Dexcom market cap?▼
Today Dexcom has the market capitalization of 22.89B
When is the next Dexcom earnings date?▼
Dexcom is going to release the next earnings report on July 23, 2026.
What were Dexcom earnings last quarter?▼
DXCM earnings for the last quarter are 0.56 USD per share, whereas the estimation was 0.47 USD resulting in a +20.27% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Dexcom revenue for the last year?▼
Dexcom revenue for the last year amounts to 9.32B USD.
What is Dexcom net income for the last year?▼
DXCM net income for the last year is 1.67B USD.
How many employees does Dexcom have?▼
As of May 06, 2026, the company has 10,200 employees.
In which sector is Dexcom located?▼
Dexcom operates in the Health & Wellness sector.
When did Dexcom complete a stock split?▼
The last stock split for Dexcom was on June 13, 2022 with a ratio of 4:1.
Where is Dexcom headquartered?▼
Dexcom is headquartered in San Diego, United States.